(2023). Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UK. Bmj Open, 13, e068718. http://doi.org/10.1136/bmjopen-2022-068718.
(2023). Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. Bmc Med, 21, 21. http://doi.org/10.1186/s12916-022-02722-5.
(2022). Protocol for development and validation of postpartum cardiovascular disease (CVD) risk prediction model incorporating reproductive and pregnancy-related candidate predictors. Diagn Progn Res, 6, 23. http://doi.org/10.1186/s41512-022-00137-7.
(2022). Systematic approach to outcome assessment from coded electronic healthcare records in the DaRe2THINK NHS-embedded randomized trial . European Heart Journal - Digital Health, 3, 426–436. http://doi.org/https://doi.org/10.1093/ehjdh/ztac046.
(2022). Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England. Bmc Med, 20, 298. http://doi.org/10.1186/s12916-022-02473-3.
(2022). Preventing unscheduled hospitalisations from asthma: a retrospective cohort study using routine primary and secondary care data in the UK (The PUSH-Asthma Study)-protocol paper. Bmj Open, 12, e058356. http://doi.org/10.1136/bmjopen-2021-058356.
(2022). Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. http://doi.org/10.1038/s41591-022-01909-w.
(2022). Long-term impact of pre-incision antibiotics on children born by caesarean section: a longitudinal study based on UK electronic health records. Health Technol Assess, 26, 1-160. http://doi.org/10.3310/zyzc8514.
(2022). Long term impact of prophylactic antibiotic use before incision versus after cord clamping on children born by caesarean section: longitudinal study of UK electronic health records. Bmj, 377, e069704. http://doi.org/10.1136/bmj-2021-069704.
(2022). Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study). Bmj Open, 12, e060413. http://doi.org/10.1136/bmjopen-2021-060413.